84 related articles for article (PubMed ID: 16155845)
21. Learning and memory in 5-HT(1A)-receptor mutant mice.
Bert B; Fink H; Rothe J; Walstab J; Bönisch H
Behav Brain Res; 2008 Dec; 195(1):78-85. PubMed ID: 18396339
[TBL] [Abstract][Full Text] [Related]
22. Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists.
Braden MR; Parrish JC; Naylor JC; Nichols DE
Mol Pharmacol; 2006 Dec; 70(6):1956-64. PubMed ID: 17000863
[TBL] [Abstract][Full Text] [Related]
23. Serotonin 1A and 2A receptor densities, neurochemical and behavioural characteristics in two closely related mice strains after long-term isolation.
Schiller L; Donix M; Jähkel M; Oehler J
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):492-503. PubMed ID: 16412547
[TBL] [Abstract][Full Text] [Related]
24. Effect of chronic treatment with clozapine and haloperidol on 5-HT(2A and 2C) receptor mRNA expression in the rat brain.
Huang XF; Tan YY; Huang X; Wang Q
Neurosci Res; 2007 Nov; 59(3):314-21. PubMed ID: 17868938
[TBL] [Abstract][Full Text] [Related]
25. Single exposure to a serotonin 1A receptor agonist, (+)8-hydroxy-2-(di-n-propylamino)-tetralin, produces a prolonged heterologous desensitization of serotonin 2A receptors in neuroendocrine neurons in vivo.
Carrasco GA; Van de Kar LD; Jia C; Xu H; Chen Z; Chadda R; Garcia F; Muma NA; Battaglia G
J Pharmacol Exp Ther; 2007 Mar; 320(3):1078-86. PubMed ID: 17159160
[TBL] [Abstract][Full Text] [Related]
26. Physiological and therapeutic relevance of constitutive activity of 5-HT 2A and 5-HT 2C receptors for the treatment of depression.
Berg KA; Harvey JA; Spampinato U; Clarke WP
Prog Brain Res; 2008; 172():287-305. PubMed ID: 18772038
[TBL] [Abstract][Full Text] [Related]
27. Expression of mRNA for multiple serotonin (5-HT) receptor types/subtypes by the peripheral blood mononuclear cells of rhesus macaques.
Yang GB; Qiu CL; Zhao H; Liu Q; Shao Y
J Neuroimmunol; 2006 Sep; 178(1-2):24-9. PubMed ID: 16814400
[TBL] [Abstract][Full Text] [Related]
28. Blockade of 5-HT 1B receptors facilitates contextual aversive learning in mice by disinhibition of cholinergic and glutamatergic neurotransmission.
Eriksson TM; Madjid N; Elvander-Tottie E; Stiedl O; Svenningsson P; Ogren SO
Neuropharmacology; 2008 Jun; 54(7):1041-50. PubMed ID: 18394658
[TBL] [Abstract][Full Text] [Related]
29. Expression patterns of 5-HT receptor subtypes 1A and 2A on GABAergic neurons within the spinal dorsal horn of GAD67-GFP knock-in mice.
Wang YY; Wei YY; Huang J; Wang W; Tamamaki N; Li YQ; Wu SX
J Chem Neuroanat; 2009 Sep; 38(1):75-81. PubMed ID: 19409978
[TBL] [Abstract][Full Text] [Related]
30. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse.
Bubar MJ; Cunningham KA
Prog Brain Res; 2008; 172():319-46. PubMed ID: 18772040
[TBL] [Abstract][Full Text] [Related]
31. Cognitive dysfunction in neuropsychiatric disorders: selected serotonin receptor subtypes as therapeutic targets.
Terry AV; Buccafusco JJ; Wilson C
Behav Brain Res; 2008 Dec; 195(1):30-8. PubMed ID: 18241938
[TBL] [Abstract][Full Text] [Related]
32. Memory formation, amnesia, improved memory and reversed amnesia: 5-HT role.
Perez-Garcia G; Meneses A
Behav Brain Res; 2008 Dec; 195(1):17-29. PubMed ID: 18221797
[TBL] [Abstract][Full Text] [Related]
33. Antagonism of serotonergic 5-HT2A/2C receptors: mutual improvement of sleep, cognition and mood?
Landolt HP; Wehrle R
Eur J Neurosci; 2009 May; 29(9):1795-809. PubMed ID: 19473234
[TBL] [Abstract][Full Text] [Related]
34. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
Meltzer HY; Huang M
Prog Brain Res; 2008; 172():177-97. PubMed ID: 18772033
[TBL] [Abstract][Full Text] [Related]
35. Modulation of cholinergic functions by serotonin and possible implications in memory: general data and focus on 5-HT(1A) receptors of the medial septum.
Jeltsch-David H; Koenig J; Cassel JC
Behav Brain Res; 2008 Dec; 195(1):86-97. PubMed ID: 18400315
[TBL] [Abstract][Full Text] [Related]
36. 5-HT4 receptor agonists increase sAPPalpha levels in the cortex and hippocampus of male C57BL/6j mice.
Cachard-Chastel M; Lezoualc'h F; Dewachter I; Deloménie C; Croes S; Devijver H; Langlois M; Van Leuven F; Sicsic S; Gardier AM
Br J Pharmacol; 2007 Apr; 150(7):883-92. PubMed ID: 17325649
[TBL] [Abstract][Full Text] [Related]
37. Substance P neurokinin 1 receptor activation within the dorsal raphe nucleus controls serotonin release in the mouse frontal cortex.
Guiard BP; Guilloux JP; Reperant C; Hunt SP; Toth M; Gardier AM
Mol Pharmacol; 2007 Dec; 72(6):1411-8. PubMed ID: 17890358
[TBL] [Abstract][Full Text] [Related]
38. Doxazosin and serotonin (5-HT) receptor (1A, 2A, and 4) antagonists inhibit 5-HT-mediated human cavernosal contraction.
Lau DH; Thompson CS; Bellringer JF; Thomas PJ; Mumtaz FH; Morgan RJ; Mikhailidis DP
J Androl; 2006; 27(5):679-85. PubMed ID: 16728720
[TBL] [Abstract][Full Text] [Related]
39. Social isolation and expression of serotonergic neurotransmission-related genes in several brain areas of male mice.
Bibancos T; Jardim DL; Aneas I; Chiavegatto S
Genes Brain Behav; 2007 Aug; 6(6):529-39. PubMed ID: 17083332
[TBL] [Abstract][Full Text] [Related]
40. Serotonergic mechanisms in aggression.
Olivier B
Novartis Found Symp; 2005; 268():171-83; discussion 183-9, 242-53. PubMed ID: 16206880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
